Skip to main content
. 2018 Jun 27;5(1):e000800. doi: 10.1136/openhrt-2018-000800

Figure 1.

Figure 1

Efficacy outcomes with dabigatran etexilate versus warfarin in Latin American (n=956) and non-Latin American (n=17157) patients. BID, twice daily; NC, not calculable; SE, systemic embolism.